{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:06:17Z","timestamp":1786997177865,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.suc.2007.03.003","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T12:54:26Z","timestamp":1181307266000},"page":"673-680","source":"Crossref","is-referenced-by-count":61,"title":["Extra-Intestinal Manifestations of Crohn's Disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Kimberly","family":"Ephgrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2007.03.003_bib1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications","volume":"77","author":"Rankin","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.003_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extra-intestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.003_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.MIB.0000201098.26450.ae","article-title":"Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central China","volume":"12","author":"Jiang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib4","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25 year follow-up study","volume":"9","author":"Lakotos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.003_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcaper","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.suc.2007.03.003_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.gtc.2006.09.001","article-title":"Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab","volume":"35","author":"Barrie","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.suc.2007.03.003_bib7","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.003_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1600-051X.2006.00942.x","article-title":"Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study","volume":"33","author":"Grossner-Schreiber","year":"2006","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.suc.2007.03.003_bib9","first-page":"7","article-title":"Early atherosclerosis in patients with inflammatory bowel disease","volume":"10","author":"Papa","year":"2006","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.suc.2007.03.003_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2006.03063.x","article-title":"Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease","author":"Stange","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.suc.2007.03.003_bib11","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3748\/wjg.v12.i38.6167","article-title":"Abnormalities of the uterine cervix in women with inflammatory bowel disease","volume":"12","author":"Bhatia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.003_bib12","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.3748\/wjg.v12.i30.4807","article-title":"Etiopathogenesis of inflammatory bowel diseases","volume":"12","author":"Danese","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2007.03.003_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","article-title":"Ocular manifestations of inflammatory bowel disease","volume":"10","author":"Mintz","year":"2004","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.suc.2007.03.003_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/01.ico.0000214206.29823.2d","article-title":"Corneal perforation due to severe peripheral ulcerative keratitis in Crohn disease","volume":"25","author":"Tan","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.suc.2007.03.003_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ajo.2006.01.075","article-title":"Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation","volume":"141","author":"Lin","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.suc.2007.03.003_bib16","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.suc.2007.03.003_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms","volume":"356","author":"Van den Bosch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.suc.2007.03.003_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","article-title":"Ankylosing spondylitis and bowel disease","volume":"20","author":"Rudwaleit","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.suc.2007.03.003_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11914-996-0031-4","article-title":"Inflammatory bowel diseases as secondary causes of osteoporosis","volume":"4","author":"Bernstein","year":"2006","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.suc.2007.03.003_bib20","first-page":"63","article-title":"Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment","volume":"6","author":"Katz","year":"2006","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.suc.2007.03.003_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000092013","article-title":"Analysis of risk factors for low bone mineral density in inflammatory bowel disease","volume":"73","author":"Frei","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.suc.2007.03.003_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00384-005-0084-3","article-title":"Bone mineral density in Iranian patients with inflammatory bowel disease","volume":"21","author":"Zali","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2230.2006.02093.x","article-title":"Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease","volume":"31","author":"Akay","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.suc.2007.03.003_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10350-005-0218-2","article-title":"Metastatic cutaneous Crohn's disease of the nipple","volume":"49","author":"Goyal","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.suc.2007.03.003_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1590-8658(03)00080-X","article-title":"Response of cutaneous Crohn's disease to infliximab and methotrexate","volume":"35","author":"Konrad","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.suc.2007.03.003_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.suc.2007.03.003_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","article-title":"Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial","volume":"51","author":"Gottlieb","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.suc.2007.03.003_bib29","article-title":"Respiratory symptoms in patients with inflammatory bowel disease and the impact of dietary salicylates","author":"Sivagnamam","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-144-12-200606200-00004","article-title":"Autoimmune diseases in asthma","volume":"144","author":"Tirosh","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.suc.2007.03.003_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1513\/pats.200512-124JH","article-title":"Bronchiolitis: the pathologist's perspective","volume":"3","author":"Visscher","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.suc.2007.03.003_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00384-006-0094-9","article-title":"Inflammatory bowel disease and the lung: is there a link between surgery and bronchiectasis?","volume":"21","author":"Kelly","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1745-0179-2-24","article-title":"Anti-depressants and inflammatory bowel disease: a systematic review","volume":"2","author":"Mikocka-Walus","year":"2006","journal-title":"Clin Pract Epidemol Ment Health"},{"key":"10.1016\/j.suc.2007.03.003_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.MIB.0000217769.83142.c6","article-title":"Psychosocial functioning in pediatric inflammatory bowel disease","volume":"12","author":"Mackner","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.physbeh.2006.06.019","article-title":"Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium","volume":"89","author":"Lyte","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.suc.2007.03.003_bib36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.suc.2007.03.003_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2006.02720.x","article-title":"Risk of schizophrenia in people with celiac disease, ulcerative colitis and Crohn's disease: a general population-based study","volume":"23","author":"West","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.suc.2007.03.003_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.MIB.0000191670.04605.e7","article-title":"Impact of chronic conditions on quality of life in patients with inflammatory bowel disease","volume":"12","author":"Pizzi","year":"2006","journal-title":"Inflamm Bowel Dis"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610907000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610907000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T17:44:04Z","timestamp":1556473444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610907000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0039610907000242"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2007.03.003","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}